Tenapanor reduces phosphate binder pill burden among hemodialysis patients in a post hoc phase 3 analysis

Nobuo Nagano, Shin Tokunaga, Shinji Asada, Masafumi Fukagawa, Tadao Akizawa

Open source

DOI
10.1038/s41598-026-58594-9
Published
2026-07-01
Container
Scientific Reports
Publisher
Springer Science and Business Media LLC
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1038/s41598-026-58594-9,
  title = {Tenapanor reduces phosphate binder pill burden among hemodialysis patients in a post hoc phase 3 analysis},
  author = {Nobuo Nagano and Shin Tokunaga and Shinji Asada and Masafumi Fukagawa and Tadao Akizawa},
  year = {2026},
  journal = {Scientific Reports},
  doi = {10.1038/s41598-026-58594-9},
  url = {https://doi.org/10.1038/s41598-026-58594-9}
}

RIS

TY  - JOUR
TI  - Tenapanor reduces phosphate binder pill burden among hemodialysis patients in a post hoc phase 3 analysis
AU  - Nobuo Nagano
AU  - Shin Tokunaga
AU  - Shinji Asada
AU  - Masafumi Fukagawa
AU  - Tadao Akizawa
PY  - 2026
JO  - Scientific Reports
DO  - 10.1038/s41598-026-58594-9
UR  - https://doi.org/10.1038/s41598-026-58594-9
ER  - 

APA

Nagano, N., Tokunaga, S., Asada, S., Fukagawa, M., & Akizawa, T. (2026). Tenapanor reduces phosphate binder pill burden among hemodialysis patients in a post hoc phase 3 analysis. Scientific Reports. https://doi.org/10.1038/s41598-026-58594-9

Source records